Combining the Tyrosine Kinase Inhibitor Cabozantinib and the mTORC1/2 Inhibitor Sapanisertib Blocks ERK Pathway Activity and Suppresses Tumor Growth in Renal Cell Carcinoma
酪氨酸激酶抑制剂卡博替尼与 mTORC1/2 抑制剂萨帕尼塞替尼联合使用可阻断 ERK 通路活性并抑制肾细胞癌的肿瘤生长
期刊:Cancer Research
影响因子:12.5
doi:10.1158/0008-5472.CAN-23-0604
Yige Wu #, Siqi Chen #, Xiaolu Yang #, Kazuhito Sato #, Preet Lal #, Yuefan Wang, Andrew T Shinkle, Michael C Wendl, Tina M Primeau, Yanyan Zhao, Alanna Gould, Hua Sun, Jacqueline L Mudd, Jeremy Hoog, R Jay Mashl, Matthew A Wyczalkowski, Chia-Kuei Mo, Ruiyang Liu, John M Herndon, Sherri R Davies, Di